Tenax Therapeutics (TENX) Tops Q1 EPS by 3c

Tenax Therapeutics (NASDAQ: TENX) reported Q1 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.

You May Also Be Interested In

• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Raymond James Upgrades Dollar Tree (DLTR) to Outperform
• Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism